We are live on ! Find out more
Jones Financial Companies

Jones Financial Companies Portfolio holdings

AUM $250B
1-Year Est. Return 21.32%
This Fund
S&P 500
This Quarter Est. Return
+1.8%
1 Year Est. Return
+21.32%
3 Year Est. Return
+54.08%
5 Year Est. Return
+44.22%
10 Year Est. Return
+135.91%
AUM
$164B
AUM Growth
+$17.2B
Cap. Flow
+$14.1B
Cap. Flow %
8.6%
Top 10 Hldgs %
59.93%
Holding
4,645
New
419
Increased
2,693
Reduced
747
Closed
249

Sector Composition

Rank Sector Weight
1 Technology 2.81%
2 Financials 1.17%
3 Consumer Discretionary 1.11%
4 Communication Services 0.99%
5 Healthcare 0.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LINE
2776
Lineage Inc
LINE
$9.58B
$29.1K ﹤0.01%
830
+165
+25% +$6.1K
NATH icon
2777
Nathan's Famous
NATH
$397M
$29K ﹤0.01%
310
+73
+31% +$7.34K
WGS icon
2778
GeneDx Holdings
WGS
$2.35B
$29K ﹤0.01%
223
+9
+4% +$1.24K
UGL icon
2779
ProShares Ultra Gold
UGL
$804M
$28.9K ﹤0.01%
520
GLP icon
2780
Global Partners
GLP
$1.71B
$28.7K ﹤0.01%
686
+82
+14% +$3.61K
MSGS icon
2781
Madison Square Garden
MSGS
$9.81B
$28.7K ﹤0.01%
111
+20
+22% +$4.55K
UHAL icon
2782
U-Haul Holding Co
UHAL
$14.4B
$28.6K ﹤0.01%
568
+112
+25% +$5.96K
CDRE icon
2783
Cadre Holdings
CDRE
$1.45B
$28.6K ﹤0.01%
700
-274
-28% -$11.4K
INSW icon
2784
International Seaways
INSW
$4.81B
$28.5K ﹤0.01%
588
+41
+7% +$2.03K
DLX icon
2785
Deluxe
DLX
$1.1B
$28.5K ﹤0.01%
1,275
+800
+168% +$16.1K
FXNC icon
2786
First National Corp
FXNC
$288M
$28.5K ﹤0.01%
1,128
KROS icon
2787
Keros Therapeutics
KROS
$200M
$28.4K ﹤0.01%
+1,396
New +$24.5K
NSP icon
2788
Insperity
NSP
$1.98B
$28.4K ﹤0.01%
734
-21
-3% -$839
TARS icon
2789
Tarsus Pharmaceuticals
TARS
$3.05B
$28.4K ﹤0.01%
347
+49
+16% +$3.66K
UTL icon
2790
Unitil
UTL
$992M
$28.4K ﹤0.01%
586
+18
+3% +$876
IMNM icon
2791
Immunome
IMNM
$2.99B
$28.4K ﹤0.01%
1,320
+320
+32% +$5.62K
NEOG icon
2792
Neogen
NEOG
$2.53B
$28.3K ﹤0.01%
4,048
+22
+0.5% +$138
IOVA icon
2793
Iovance Biotherapeutics
IOVA
$2.98B
$28.2K ﹤0.01%
10,341
+5,100
+97% +$11.8K
GKOS icon
2794
Glaukos
GKOS
$10.9B
$28.2K ﹤0.01%
250
+44
+21% +$4.2K
XIFR
2795
XPLR Infrastructure LP
XIFR
$1.1B
$28.2K ﹤0.01%
2,820
-4,427
-61% -$42.9K
ENZL icon
2796
iShares MSCI New Zealand ETF
ENZL
$82.8M
$28.1K ﹤0.01%
620
SEMR
2797
DELISTED
Semrush
SEMR
$27.9K ﹤0.01%
2,348
-289
-11% -$2.71K
NAK
2798
Northern Dynasty Minerals
NAK
$919M
$27.8K ﹤0.01%
14,129
+6,685
+90% +$12.9K
AMBA icon
2799
Ambarella
AMBA
$3.57B
$27.8K ﹤0.01%
392
+126
+47% +$10.2K
SRRK icon
2800
Scholar Rock
SRRK
$6.38B
$27.8K ﹤0.01%
630

Similar funds

Jones Financial Companies's Q4 2025 Portfolio in Review

As of Q4 2025, Jones Financial Companies held 4,645 positions worth $164B, up 12% from $147B the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Jones Financial Companies deployed $14.1B of net new capital in Q4 2025, opening 419 new positions and adding to 2,693 existing holdings. Its largest new stake was Pacer Data and Digital Revolution ETF: 59,780 shares worth $3.83M.

By sector, the portfolio is most concentrated in Technology at 2.8% of assets, up from 2.8% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was iShares Core US Aggregate Bond ETF, an estimated $538M trimmed.

  • Jones Financial Companies's largest Q4 2025 buy was Pacer Data and Digital Revolution ETF: 59,780 shares worth $3.83M.
  • Jones Financial Companies added most to Vanguard Morningstar Growth ETF in Q4 2025, an estimated $2.03B increase.
  • Jones Financial Companies's biggest Q4 2025 reduction was iShares Core US Aggregate Bond ETF, cutting an estimated $538M.
  • Jones Financial Companies fully exited Invesco BulletShares 2025 Corporate Bond ETF in Q4 2025, selling an estimated $7.65M.
  • Jones Financial Companies's ten largest holdings make up 60% of its $164B portfolio in Q4 2025.
  • Jones Financial Companies opened 419 new positions and closed 249 in Q4 2025.
  • Jones Financial Companies's portfolio value rose 12% quarter-over-quarter to $164B.

Based on Jones Financial Companies's 13F filing for Q4 2025, filed 17 Feb 2026.